Details for New Drug Application (NDA): 086101
✉ Email this page to a colleague
NDA 086101 describes SECONAL SODIUM, which is a drug marketed by Valeant Pharms North and Lilly and is included in three NDAs. Additional details are available on the SECONAL SODIUM profile page.
The generic ingredient in SECONAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. Additional details are available on the secobarbital sodium profile page.
The generic ingredient in SECONAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. Additional details are available on the secobarbital sodium profile page.
Summary for 086101
| Tradename: | SECONAL SODIUM |
| Applicant: | Valeant Pharms North |
| Ingredient: | secobarbital sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086101
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
| Approval Date: | Oct 3, 1983 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
| Approval Date: | Oct 3, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
